{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:07:30Z","timestamp":1779782850095,"version":"3.53.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100010900","name":"Yale Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s11060-026-05615-2","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:56:57Z","timestamp":1778864217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disparities in stereotactic radiosurgery receipt in patients with brain metastases from non-small cell lung cancer"],"prefix":"10.1007","volume":"177","author":[{"given":"Kelly","family":"Becht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan E.","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela R.","family":"Soulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Aneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica L.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"5615_CR1","unstructured":"Lung cancer statistics (2025). Centers for disease control and prevention. Updated June 10. https:\/\/www.cdc.gov\/lung-cancer\/statistics\/index.html.\u00a0 Accessed 13 April 2026"},{"issue":"1","key":"5615_CR2","doi-asserted-by":"publisher","first-page":"e70043","DOI":"10.3322\/caac.70043","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A (2026) Cancer statistics, 2026. CA Cancer J Clin 76(1):e70043. https:\/\/doi.org\/10.3322\/caac.70043","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"5615_CR3","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","volume":"22","author":"JS Barnholtz-Sloan","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22(14):2865\u20132872. https:\/\/doi.org\/10.1200\/JCO.2004.12.149","journal-title":"J Clin Oncol"},{"issue":"9422","key":"5615_CR4","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","volume":"363","author":"DW Andrews","year":"2004","unstructured":"Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665\u20131672. https:\/\/doi.org\/10.1016\/S0140-6736(04)16250-8","journal-title":"Lancet"},{"issue":"21","key":"5615_CR5","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","volume":"295","author":"H Aoyama","year":"2006","unstructured":"Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295(21):2483\u20132491. https:\/\/doi.org\/10.1001\/jama.295.21.2483","journal-title":"JAMA"},{"issue":"3","key":"5615_CR6","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.ijrobp.2020.07.2108","volume":"108","author":"J Li","year":"2020","unstructured":"Li J, Ludmir EB, Wang Y et al (2020) Stereotactic radiosurgery versus whole-brain radiation therapy for patients with 4\u201315 brain metastases: a phase III randomized controlled trial. Int J Radiat Oncol Biol Phys 108(3):S21\u2013S22. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.07.2108","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5615_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3171\/2012.4.JNS11870","volume":"117","author":"R Grandhi","year":"2012","unstructured":"Grandhi R, Kondziolka D, Panczykowski D et al (2012) Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases. J Neurosurg 117(2):237\u2013245. https:\/\/doi.org\/10.3171\/2012.4.JNS11870","journal-title":"J Neurosurg"},{"key":"5615_CR8","doi-asserted-by":"publisher","unstructured":"DiGiulio S (2014) ASTRO Releases its second choosing wisely\u2019 List. Oncol Times. October 10;36(19):18. https:\/\/doi.org\/10.1097\/01.COT.0000455779.64927.57.","DOI":"10.1097\/01.COT.0000455779.64927.57"},{"issue":"2","key":"5615_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijrobp.2012.05.002","volume":"85","author":"DC Hodgson","year":"2013","unstructured":"Hodgson DC, Charpentier AM, Cigsar C et al (2013) A multi-institutional study of factors influencing the use of stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 85(2):335\u2013340. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.05.002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5615_CR10","unstructured":"State of Lung Cancer (2024) Racial and ethnic disparities. American lung association. Updated June 7. https:\/\/www.lung.org\/research\/state-of-lung-cancer\/racial-and-ethnic-disparities Accessed 20 Aug 2024."},{"key":"5615_CR11","unstructured":"National Cancer Institute SEER-Medicare: brief description of the SEER-medicare database. division of cancer control and population sciences \u2013 healthcare delivery research program. Updated May 16, 2019 https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/overview\/. Accessed 18 Sept 2024."},{"issue":"8 Suppl","key":"5615_CR12","doi-asserted-by":"publisher","first-page":"IV","DOI":"10.1097\/01.MLR.0000020942.47004.03","volume":"40","author":"JL Warren","year":"2002","unstructured":"Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):IV\u201318. https:\/\/doi.org\/10.1097\/01.MLR.0000020942.47004.03","journal-title":"Med Care"},{"key":"5615_CR13","unstructured":"National Cancer Institute (2024). Overview of the SEER Program. Surveillance, Epidemiology, and End Results Program. https:\/\/seer.cancer.gov\/about\/overview.html. Accessed 18 Sept 2024."},{"issue":"1","key":"5615_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36(1):8\u201327. https:\/\/doi.org\/10.1097\/00005650-199801000-00004","journal-title":"Med Care"},{"issue":"7","key":"5615_CR15","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/gerona\/glx229","volume":"73","author":"DH Kim","year":"2018","unstructured":"Kim DH, Schneeweiss S, Glynn RJ, Lipsitz LA, Rockwood K, Avorn J (2018) Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index. J Gerontol Biol Sci Med Sci 73(7):980\u2013987. https:\/\/doi.org\/10.1093\/gerona\/glx229","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"8","key":"5615_CR16","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/gerona\/gly197","volume":"74","author":"DH Kim","year":"2019","unstructured":"Kim DH, Glynn RJ, Avorn J et al (2019) Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study. J Gerontol Biol Sci Med Sci 74(8):1271\u20131276. https:\/\/doi.org\/10.1093\/gerona\/gly197","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"2","key":"5615_CR17","doi-asserted-by":"publisher","first-page":"e4031","DOI":"10.7759\/cureus.4031","volume":"11","author":"A Modh","year":"2019","unstructured":"Modh A, Doshi A, Burmeister C, Elshaikh MA, Lee I, Shah M (2019) Disparities in the Use of Single-fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases From Non-small Cell Lung Cancer. Cureus 11(2):e4031 Published 2019 Feb 7. https:\/\/doi.org\/10.7759\/cureus.4031","journal-title":"Cureus"},{"issue":"4","key":"5615_CR18","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3171\/2015.4.JNS1573","volume":"124","author":"HS Park","year":"2016","unstructured":"Park HS, Wang EH, Rutter CE, Corso CD, Chiang VL, Yu JB (2016) Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US. J Neurosurg 124(4):1018\u20131024. https:\/\/doi.org\/10.3171\/2015.4.JNS1573","journal-title":"J Neurosurg"},{"issue":"21","key":"5615_CR19","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.3390\/cancers15215226","volume":"15","author":"JM Hall","year":"2023","unstructured":"Hall JM, Mkuu RS, Cho HD et al (2023) Disparities Contributing to Late-Stage Diagnosis of Lung, Colorectal, Breast, and Cervical Cancers: Rural and Urban Poverty in Florida. Cancers (Basel) 15(21):5226. https:\/\/doi.org\/10.3390\/cancers15215226. Published 2023 Oct 31","journal-title":"Cancers (Basel)"},{"issue":"7","key":"5615_CR20","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/jnci\/djac030","volume":"114","author":"S Bhatia","year":"2022","unstructured":"Bhatia S, Landier W, Paskett ED et al (2022) Rural-Urban Disparities in Cancer Outcomes: Opportunities for Future Research. J Natl Cancer Inst 114(7):940\u2013952. https:\/\/doi.org\/10.1093\/jnci\/djac030","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"5615_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.adro.2018.09.002","volume":"4","author":"HK Perlow","year":"2018","unstructured":"Perlow HK, Cassidy V, Farnia B et al (2018) Impact of Performance Status and Comorbidity on Palliative Radiation Treatment Tolerance and End-Of-Life Decision-Making. Adv Radiat Oncol 4(1):127\u2013133 Published 2018 Sep 14. https:\/\/doi.org\/10.1016\/j.adro.2018.09.002","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"5615_CR22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jpainsymman.2021.12.030","volume":"63","author":"D Fortuna","year":"2022","unstructured":"Fortuna D, Caselli L, Banchelli F, Moro ML, Costantini M (2022) How Many Cancer Patients Need Palliative Care? A Population-Based Study. J Pain Symptom Manage 63(4):468\u2013475. https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.12.030","journal-title":"J Pain Symptom Manage"},{"key":"5615_CR23","unstructured":"National Cancer Institute. Cancer Disparities. Updated March 21 (2024). https:\/\/www.cancer.gov\/about-cancer\/understanding\/disparities.\u00a0Accessed 13 Sept 2024"},{"issue":"6","key":"5615_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.surneu.2006.08.002","volume":"66","author":"DW Andrews","year":"2006","unstructured":"Andrews DW, Bednarz G, Evans JJ, Downes B (2006) A review of 3 current radiosurgery systems. Surg Neurol 66(6):559\u2013564. https:\/\/doi.org\/10.1016\/j.surneu.2006.08.002","journal-title":"Surg Neurol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05615-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05615-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05615-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:58:18Z","timestamp":1779782298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05615-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["5615"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05615-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is approved for IRB exemption (Protocol ID: 2000035458).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The data used in this study is derived from de-identified SEER database Participant User Files. This study is approved for IRB exemption with waiver of informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"James E. Hansen: Patrys Ltd (patents, consulting, research funding, stock\/options). Sarah B. Goldberg: Amgen (consulting, advisory board), AstraZeneca (consulting, advisory board, research funding), Boehringer Ingelheim (research funding), Bristol-Myers Squibb (consulting, advisory board), Daiichi-Sankyo (consulting, advisory board), Eli Lilly (consulting, advisory board), Janssen (consulting, advisory board), Merck (consulting, advisory board), Mirati (research funding), Regeneron (consulting, advisory board), Sanofi Genzyme (consulting, advisory board), Summit Therapeutics (consulting, advisory board), Takeda (consulting, advisory board). Henry S. Park: AstraZeneca (consulting, advisory board), Bristol Myers Squibb (speaking fees\/honoraria), Curio Sciences (consulting), G1 Therapeutics (speaking fees\/honoraria), Galera Medical (advisory board), Merck (research funding), Regeneron Pharmaceuticals (advisory board), RefleXion Medical (research funding, consulting). No additional disclosures from other authors related to the following research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}